4163.SRライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (5 5月 2024 @ 21:17):

Al-Dawaa Medical Services Company operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. The company operates through Retail and Wholesale segments...

Stats
本日の出来高	113 510
平均出来高	234 668
時価総額	8.08B
EPS	SAR0.839 ( 2023-10-31 )
次の収益日	( SAR0 ) 2024-05-22
Last Dividend	SAR0 ( N/A )
Next Dividend	SAR0 ( N/A )
P/E	24.57
ATR14	SAR0.0490 (0.05%)

ボリューム相関

長: 0.18 (neutral)

短: 0.00 (neutral)

Signal:(53.303) Neutral

Al-Dawaa Medical Services 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Al-Dawaa Medical Services 相関 - 通貨/商品

-0.18
( neutral )

-0.31
( neutral )

0.21
( neutral )

-0.29
( neutral )

-0.25
( neutral )

Al-Dawaa Medical Services 財務諸表

Annual	2023
収益:	SAR5.74B
総利益:	SAR2.11B (36.69 %)
EPS:	SAR3.87

FY	2023
収益:	SAR5.74B
総利益:	SAR2.11B (36.69 %)
EPS:	SAR3.87

FY	2022
収益:	SAR5.37B
総利益:	SAR2.02B (37.59 %)
EPS:	SAR3.59

Financial Reports:

No articles found.

Al-Dawaa Medical Services

Al-Dawaa Medical Services Company operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. The company operates through Retail and Wholesale segments. It offers medicines, perfumes, beauty tools and products, cosmetics, and other pharmaceutical products. The company is also involved in pharmacy activities, pharmaceutical warehouse activities, retailing of medical equipment, land transport of goods, managing and renting self-storage stores, and provision of marketing services on behalf of third parties, as well as acting as a pharmaceutical agent. It operates through a network of 837 pharmacies. In addition, the company sells its pharmaceutical products through online and wholesale channels. Al-Dawaa Medical Services Company was founded in 1991 and is based in Al Khobar, the Kingdom of Saudi Arabia.